Wednesday, September 5
12:30 – 4:30 PM
Location: Regency Ballrom A, Hyatt Regency Convention Center
Co-Chairs: James P. Higgins, MD, Richard A. Bernstein, MD, Martin I. Boyer, MD, FRCS(C)
Fees
Members – $195
Nonmembers – $225
Senior Members - $145
Residents & Fellows – $75
Allied Health – $125
CME: The ASSH designates this live educational activity for a maximum of 3.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Audience Level: Intermediate
Description
Part 2 of the full day course will present the latest information on the diagnosis and treatment of neurological and vascular disorders of the upper extremity. An expert panel will provide a comprehensive overview of current diagnostic treatment algorithms. The afternoon session will focus on the most common vascular disorders that face the hand surgeon. Through a series of didactic sessions and case presentations, the participants will review our current understanding of neurovascular disorders of the upper extremity.
Learning Objectives
- Understand the current diagnostic and therapeutic approaches to entrapment neuropathies.
- Understand the microsurgical approaches to traumatic nerve injuries of the upper extremity.
- Demonstrate the methodology for the assessment and treatment of traumatic and vascular disorders.
- Discuss the evaluation and workup of inflammatory vascular disorders of the upper extremity.
Back to Pre-/Post-Course Listing
Faculty
Guillermo A. Ameer, Sc. D
Richard A. Bernstein, MD
Martin I. Boyer, MD, FRCS(C)
Christopher L. Forthman, MD
Navyash Gupta, MD
James P. Higgins, MD
Ryan Katz, MD
Michael A. McClinton, MD
Wyndell H. Merritt, MD
Michael W. Neumeister, MD
William H. Pearce, MD
W. Bradford Rockwell, MD
Keith A. Segalman, MD
Robert L. Vogelzang, MD
Ethan R. Wiesler, MD
Program
| 12:30 |
Welcome |
James P. Higgins, MD |
| 12:35 |
Upper Extremity Arterial Anatomy/Angiography Interpretation |
James P. Higgins, MD |
| 12:45 |
Acute Management of Brachial/Radial/Ulnar Artery Lacerations |
Keith A. Segalman, MD |
| 1:00 |
Digital Revascularization: Techniques and Outcomes |
Ryan Katz, MD |
| 1:15 |
Supracondylar Humerus Fractures with Arterial Compromise: Diagnosis and Management |
Christopher L. Forthman, MD |
| 1:30 |
Quantifying perfusion: Arterial Non-Invasive studies |
Ethan R. Wiesler, MD |
| 1:45 |
Surgical Management of Upper Extremity Vaso-occlusive Disease at the Wrist and Hand |
Michael A. McClinton, MD |
| 2:00 |
Reassessment of the Importance of the Radial Artery |
James P. Higgins, MD |
| 2:10 |
Periarterial Sympathectomy: Techniques and Results ▲ |
Wyndell H. Merritt, MD |
| 2:25 |
Break |
|
| 2:40 |
Botulinum A: Application in Upper Extremity Vascular Disease and Injury |
Michael W. Neumeister, MD |
| 2:55 |
Arterial Grafts for Acute and Chronic Arterial Reconstruction |
W. Bradford Rockwell, MD |
| 3:05 |
Bioengineering of Vascular Conduits |
Guillermo A. Ameer, Sc. D |
| 3:20 |
Surgical Management of Thoracic Outlet Syndrome |
William H. Pearce, MD |
| 3:40 |
Complications of ArterioVenous Fistulas: Diagnosis and Management |
Navyash Gupta, MD |
| 4:00 |
Use of Thrombolytics in Upper Extremity Vascular Disease |
Robert L. Vogelzang, MD |
| 4:15 |
Discussion and Cases |
James P. Higgins, MD, Richard A. Bernstein, MD, Martin I. Boyer, MD, FRCS(C) |
▲ Precourse 5: Periarterial Sympathectomy: Techniques and Results will include discussion of Botox, an "off-label" or other non-FDA approved, investigational pharmaceutical product manufactured by Allergan.